These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30709635)

  • 1. [Primary skin lymphomas: Current therapy].
    Dereure O
    Ann Dermatol Venereol; 2019 Feb; 146(2):92-99. PubMed ID: 30709635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New and experimental skin-directed therapies for cutaneous lymphomas.
    Farkas A; Kemeny L; French LE; Dummer R
    Skin Pharmacol Physiol; 2009; 22(6):322-34. PubMed ID: 19786826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulators in the treatment of cutaneous lymphomas.
    Dummer R
    Expert Opin Biol Ther; 2002 Mar; 2(3):279-86. PubMed ID: 11890867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous primary B-cell lymphomas: from diagnosis to treatment.
    Lima M
    An Bras Dermatol; 2015; 90(5):687-706. PubMed ID: 26560215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lymphomas: A therapeutic update].
    Wolfromm A; Delarue R
    Rev Med Interne; 2017 Oct; 38(10):685-690. PubMed ID: 28958786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous lymphomas.
    Klemke CD
    J Dtsch Dermatol Ges; 2014 Jan; 12(1):7-28; quiz 29-30. PubMed ID: 24393310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of targeted therapies for B-cell non-Hodgkin lymphoma and multiple myeloma.
    Hernandez-Ilizaliturri FJ; Gowda A; Czuczman MS
    Clin Adv Hematol Oncol; 2004 Sep; 2(9):606-18. PubMed ID: 16163245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous B-cell lymphomas - pathogenesis, diagnostic workup, and therapy.
    Nicolay JP; Wobser M
    J Dtsch Dermatol Ges; 2016 Dec; 14(12):1207-1224. PubMed ID: 27992127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innovative strategies in lymphoma therapy.
    Jäger U
    Wien Klin Wochenschr; 2003 Aug; 115(13-14):462-70. PubMed ID: 13677264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and emerging treatment strategies for cutaneous T-cell lymphoma.
    Lansigan F; Foss FM
    Drugs; 2010 Feb; 70(3):273-86. PubMed ID: 20166766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Reactions of Antibody-Therapy for Primary Cutaneous Lymphomas: Rituximab, Brentuximab Vedotin, Alemtuzumab, and Mogamulizumab.
    Saulite I; Guenova E; Hoetzenecker W
    Curr Probl Dermatol; 2018; 53():70-81. PubMed ID: 29131039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of the primary cutaneous lymphomas.
    Prince HM; McCormack C; Ryan G; O'Keefe R; Seymour JF; Baker C
    Australas J Dermatol; 2003 Nov; 44(4):227-40; quiz 241-2. PubMed ID: 14616487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal Antibodies.
    Geskin LJ
    Dermatol Clin; 2015 Oct; 33(4):777-86. PubMed ID: 26433849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Existing and Emerging Therapies for Cutaneous T-Cell Lymphoma.
    Van-de-Velde V; Zhou Y
    J Cutan Med Surg; 2019; 23(3):319-327. PubMed ID: 30943788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-Based Therapies for Cutaneous T-Cell Lymphoma.
    Welborn M; Duvic M
    Am J Clin Dermatol; 2019 Feb; 20(1):115-122. PubMed ID: 30430444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma.
    Fanale MA; Younes A
    Drugs; 2007; 67(3):333-50. PubMed ID: 17335294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of monoclonal antibody therapies in lymphoma.
    Teo EC; Chew Y; Phipps C
    Crit Rev Oncol Hematol; 2016 Jan; 97():72-84. PubMed ID: 26318093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies against cutaneous T-cell lymphomas.
    Alaibac M
    Expert Opin Biol Ther; 2017 Dec; 17(12):1503-1510. PubMed ID: 28829215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of refractory early-stage cutaneous T-cell lymphoma.
    Huber MA; Staib G; Pehamberger H; Scharffetter-Kochanek K
    Am J Clin Dermatol; 2006; 7(3):155-69. PubMed ID: 16734503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.